Comparison of the efficacy of Tadalafil, Tolterodine and Placebo in reduction of symptoms severity of women with Urgency, frequency syndrome/Overactive bladder

Trial Profile

Comparison of the efficacy of Tadalafil, Tolterodine and Placebo in reduction of symptoms severity of women with Urgency, frequency syndrome/Overactive bladder

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 15 Sep 2016

At a glance

  • Drugs Tadalafil (Primary) ; Tolterodine
  • Indications Overactive bladder; Urinary incontinence
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Jun 2013 New trial record
    • 22 May 2013 Recruitment complete
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top